Some supportive treatments deserve attention precisely because they do not come in a bottle. Music therapy is one of them. The interesting question is not whether music can feel comforting. It is whether a structured intervention improves anxiety enough to matter—and how it compares with an established treatment.
Evidence at a glance
Population: cancer survivors with anxiety. Intervention: individualized, therapist-led music therapy delivered remotely. Best new evidence: noninferiority to cognitive behavioral therapy in a 300-person randomized trial. Bottom line: a credible supportive-care option, not evidence of cancer control and not proof that ordinary music listening produces the same result.
What the 2026 trial found
The MELODY trial, published online January 6, 2026, assigned 300 cancer survivors to seven weekly telehealth sessions of music therapy or cognitive behavioral therapy (CBT). At eight weeks, anxiety scores on the Hospital Anxiety and Depression Scale fell by 3.12 points with music therapy and 2.97 with CBT. Both changes were clinically meaningful. Improvement persisted through week 26.
Music therapy met the study’s prespecified noninferiority criterion: the results ruled out it being worse than CBT by more than the trial’s chosen margin. That is not a claim of superiority, or a guarantee that the two approaches work equally well for every person. There was no untreated comparison group, and participants knew which treatment they received. The population was predominantly female and White, limiting how confidently we generalize.
According to the study’s funder summary, sessions were individual, approximately 60 minutes long, and delivered over seven weeks. This was a therapeutic relationship with a structured program—not simply a recommendation to turn on relaxing music. Access to a trained therapist and reliable technology are part of what made this intervention possible.
How this fits the wider evidence
A 2021 Cochrane review included 81 trials involving 5,576 people with cancer. It found signals of benefit for anxiety and some other symptoms, but certainty for the pooled anxiety result was very low. Studies varied substantially, and blinding was difficult. Therapist-delivered music therapy and listening to prerecorded music were not interchangeable interventions.
The 2023 SIO–ASCO anxiety guideline said music therapy or music-based interventions may be offered for anxiety during active cancer treatment. That recommendation preceded MELODY. The newer survivor trial strengthens a specific comparison with CBT; it does not settle every question about music during chemotherapy, severe psychiatric illness, or long-term outcomes.
Safety and practical boundaries
MELODY reported three mild adverse events in the music group and one in the CBT group, including emotional symptoms. Low physical risk does not mean an emotionally neutral experience. My practical reading is to allow room to change the music, pause, or choose another approach if sessions bring up distress. Persistent anxiety deserves assessment, including whether psychotherapy, medication, or both are needed. Symptom relief should never be presented as tumor treatment.
Questions for the care team
- Is therapist-led music therapy available, and what training does the practitioner have?
- Would CBT, music therapy, or another approach best match my symptoms and preferences?
- What would meaningful improvement look like for my sleep, worry, or daily functioning?
- How will we monitor distress and change course if the intervention is not helping?
Evidence checked October 15, 2026. Educational review; research doses and schedules are not personal prescriptions. Explore the Missing Script article library and the podcast—coming soon.
